DETROIT – The University of Michigan’s Dr. A. Oveta Fuller specializes in immunology and microbiology.
The FDA advisory committee that recommended the Pfizer vaccine largely agreed it was safe and effective. 17 members voted for it and four voted against it.
One of those No votes came from Oveta, a virologist and viral pathogen researcher. She said she was concerned about the vaccine’s long-term impact.
WATCH Local 4 News at 11
Metro Detroit weather: Cloudy Friday evening, rainy Friday night
Temperatures remain above freezing this evening and tonight and for much of the weekend. This is key because we are precipitation arriving. The higher temps mean rain instead of snow. Does become chillier but, fortunately, drier next week.
4 Fast Facts
- The family of an Eastern Michigan University student who was found murdered in her apartment in 2012 are still looking for justice. Click here to read more.
- The Detroit Rescue Mission’s Genesis House II is doing amazing things for women and children in Detroit without a place to call home. Click here to read more.
- The closure of the border between the U.S. and Canada has yet again been extended amid the coronavirus pandemic. Click here to read more.
- The Pfizer plant in Portage is one of two plants ready to rollout the COVID-19 vaccine. Click here to read more.
As a coronavirus vaccine nears approval and distribution in the U.S., Michigan officials have determined who in the state will receive the first doses of the vaccination. Due to limited quantities of and high demand for a COVID-19 vaccine, states are planning to administer the vaccinations in multiple phases, prioritizing individuals who are at greater risk.
The Michigan Bureau of Employment Relations, Wage and Hour Division announced that the state’s scheduled minimum wage increase is not expected to go into effect on Jan. 1, 2021. Michigan’s Improved Workforce Opportunity Wage Act of 2018 does not allow scheduled minimum wage increases when the state’s annual unemployment rate for the preceding calendar year is above 8.5 percent.
As Pfizer’s vaccine moves closer to rolling out, concerns remain about the allergic reactions suffered by two U.K. health care workers. The Food and Drug Administration’s vaccine advisory committee pushed Pfizer for more safety considerations that go beyond the clinical trial. They want more data, more research on the possible allergic reactions.